Amarin (AMRN) Peer Comparison

$13.66

$-0.06 (-0.40%)

As on 04-Sep-2026 12:33EDT

Market cap

$295 Mln

Revenue (TTM)

$186 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Edit

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Market cap ($ Mln)	295	16,765	16,261	13,492	12,332
Revenue ($ Mln)	186	2,782	1,054	2,436	1,284
Net Profit ($ Mln)	-27.12	491.50	755.85	860.62	-325.10
Net Margin (%)	-14.57	17.67	71.69	35.33	-25.32
RoE (%)	-6.01	110.09	--	42.98	-57.72
Price to Earnings	--	35.25	19.00	17.40	--
Price-To-Book	0.67	39.29	9.76	7.42	23.98

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Operating Revenue	186.16	2,782.29	1,054.37	2,435.92	1,283.94
Cost of Revenue	108.76	1,982.07	103.47	85.67	109.42
Gross Profit	120.87	760.62	588.53	2,236.43	902.26
Operating Expenses	110.74	216.81	841.45	1,378.74	1,497.13
Operating Profit (EBIT)	-33.34	583.40	109.45	971.51	-322.62
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-25.56	598.92	101.11	1,035.47	-325.10
Provision for Tax	1.56	107.42	-654.74	174.84	0.00
Profit after Tax (Net Income)	-27.12	491.50	755.85	860.62	-325.10
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Shareholder's Funds	443.62	433.86	1,435.90	1,843.76	523.72
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	16.55	187.89	384.48	288.55	346.72
Current Liabilities	164.20	1,435.43	464.70	361.93	374.20
Total Liabilities	670.77	1,975.47	1,302.02	2,844.42	1,259.59

Assets ($ Mln)

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Non-Current Assets	21.61	1,006.90	895.24	1,243.41	45.47
Current Assets	602.76	1,050.29	1,389.84	1,250.82	1,199.18
Total Assets	670.77	1,975.47	1,302.02	2,844.42	1,259.59
Total Debt*	5.26	120.10	449.89	165.93	347.75
Net Current Assets	438.56	-385.14	0.00	888.90	824.98

Cashflow ($ Mln)

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Cash From Operating Activities	6.74	713.22	51.77	884.27	-189.55
Cash Flow from Investing Activities	8.85	-31.14	-8.15	350.44	32.32
Cash from Financing Activities	-2.04	-860.39	34.89	-969.59	255.98
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
ROCE (%)	-8.04	53.56	-30.01	32.82	-31.49
ROE (%)	-6.01	110.09	163.18	42.98	-57.72
ROA (%)	-3.30	15.64	26.53	29.32	-22.97
EBIT Margin (%)	-12.10	21.13	5.73	31.04	-18.97
Net Margin (%)	-14.57	17.67	71.69	35.33	-25.32
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Revenue Growth (%)	-15.14	24.67	114.85	9.23	149.04
EBIT Growth (%)	66.02	18.70	136.39	-3.99	9.16
Net Profit Growth (%)	73.82	17.50	378.76	42.89	-15.32
EPS Growth (%)	74.16	26.84	353.27	50.42	-0.64
Book Value Growth (%)	-5.03	164.02	816.12	-0.70	-42.66

Valuation Ratios

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Price / Earnings	-7.48	36.06	-59.76	15.79	-45.32
Price / Book Value	0.63	35.44	-80.42	5.72	21.68
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	0.01	28.08	-121.54	12.44	-47.02
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debt to Equity	0.00	0.00	0.00	0.00	0.65
Short term debt to equity ratio	0.00	0.00	0.05	0.00	0.00
Current Ratio	3.67	0.73	2.99	3.46	3.20
Quick Ratio	2.67	0.73	2.32	3.38	2.94
Interest Coverage	-25,556.77	--	1.62	--	-19.80

Operating Efficiency Ratios

	Amarin (AMRN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debtors to sales (%)	49.91	15.88	21.25	13.74	14.98
Asset Turnover	0.23	0.89	0.37	0.83	0.91
Receivable days	212.94	50.42	85.52	43.48	35.88
Inventory Days	712.48	--	1,056.70	96.17	354.23
Payable days	168.73	6.26	331.01	147.97	300.79
Cash Conversion Cycle	756.69	--	811.21	-8.32	89.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly